Animal Vaccine Trends and Forecast
The future of the global animal vaccine market looks promising with opportunities in the companion, livestock, and aquaculture markets. The global animal vaccine market is expected to grow with a CAGR of 6.1% from 2024 to 2030. The major drivers for this market are increase in the incidence of animal disease, rising government funding for the production of veterinary vaccines, and increasing virus outbreaks in companion animal and livestock populations.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Animal Vaccine by Segment
The study includes a forecast for the global animal vaccine by product, animal type, and region.
Animal Vaccine Market by Product [Shipment Analysis by Value from 2018 to 2030]:
• Attenuated Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• Conjugate Vaccines
• Recombinant Vaccines
• DNA Vaccines
Animal Vaccine Market by Animal Type [Shipment Analysis by Value from 2018 to 2030]:
• Companion Animal
• Livestock Animal
• Aquaculture
Animal Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Animal Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies animal vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the animal vaccine companies profiled in this report include-
• Merck & Co.
• Zoetis
• Ceva Santé Animale
• Sanofi S.A.
• Romvac
Animal Vaccine Market Insights
Lucintel forecasts that attenuated is expected to witness the highest growth over the forecast period.
Within this market, livestock is expected to witness the highest growth.
North America is expected to witness highest growth over the forecast period.
Features of the Global Animal Vaccine Market
Market Size Estimates: Animal vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Animal vaccine market size by product, animal type, and region in terms of value ($B).
Regional Analysis: Animal vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different products, animal types, and regions for the animal vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the animal vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for animal vaccine market?
Answer: The global animal vaccine market is expected to grow with a CAGR of 6.1% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the animal vaccine market?
Answer: The major drivers for this market are increase in the incidence of animal disease, rising government funding for the production of veterinary vaccines, and increasing virus outbreaks in companion animal and livestock populations.
Q3. What are the major segments for animal vaccine market?
Answer: The future of the animal vaccine market looks promising with opportunities in the companion, livestock, and aquaculture markets.
Q4. Who are the key animal vaccine market companies?
Answer: Some of the key animal vaccine companies are as follows:
• Merck & Co.
• Zoetis
• Ceva Santé Animale
• Sanofi S.A.
• Romvac
Q5. Which animal vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that attenuated is expected to witness the highest growth over the forecast period.
Q6. In animal vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the animal vaccine market by product (attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and dna vaccines), animal type (companion animal , livestock animal , and aquaculture), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Animal Vaccine Market, Animal Vaccine Market Size, Animal Vaccine Market Growth, Animal Vaccine Market Analysis, Animal Vaccine Market Report, Animal Vaccine Market Share, Animal Vaccine Market Trends, Animal Vaccine Market Forecast, Animal Vaccine Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.